日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant chemotherapy for high-risk upper tract urothelial cancer

高危上尿路尿路上皮癌的新辅助化疗

Malshy, Kamil; Messing, Edward M

Circulating tumor DNA-guided adjuvant immunotherapy in muscle-invasive bladder cancer

循环肿瘤DNA引导的辅助免疫疗法治疗肌层浸润性膀胱癌

Malshy, Kamil; Messing, Edward M

Single-Arm Pivotal Studies in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer

卡介苗不敏感型非肌层浸润性膀胱癌的单臂关键性研究

Bandari, Jathin; Messing, Edward M

Protein disulfide isomerase-enriched extracellular vesicles from bladder cancer cells support tumor survival and malignant transformation in the bladder

膀胱癌细胞中富含蛋白质二硫键异构酶的细胞外囊泡支持肿瘤细胞存活和膀胱恶性转化

Wu, Chia-Hao; Yuen, Kit L; Molony, Ryan D; Silvers, Christopher R; Akash, Md Mahmudul Hasan; Messing, Edward M; Lee, Yi-Fen

Standard vs extended lymphadenectomy for muscle invasive bladder cancer

肌层浸润性膀胱癌的标准淋巴结清扫术与扩大淋巴结清扫术

Messing, Edward M

When a 'routine' TURBT is not routine: Lessons from SEER-medicare

当“常规”经尿道膀胱肿瘤切除术(TURBT)并非常规:来自SEER-Medicare的经验教训

Malshy, Kamil; Messing, Edward M

Can urinary tumor DNA be used to assess the risk of recurrence in patients with non-muscle invasive bladder cancer?

尿液肿瘤DNA能否用于评估非肌层浸润性膀胱癌患者的复发风险?

Malshy, Kamil; Messing, Edward M

Roles of Androgen Receptor Signaling in Urothelial Carcinoma

雄激素受体信号传导在尿路上皮癌中的作用

Sundi, Debasish; Collier, Katharine A; Yang, Yuanquan; Diaz, Dayssy Alexandra; Pohar, Kamal S; Singer, Eric A; Gupta, Sanjay; Carson, William E 3rd; Clinton, Steven K; Li, Zihai; Messing, Edward M

Do All Low Risk Microhematuria Patients Require Cystoscopy?

所有低风险微量血尿患者都需要进行膀胱镜检查吗?

Messing, Edward M

Urologists and Advanced Practice Providers Evaluating Hematuria

泌尿科医生和高级执业医师评估血尿

Messing, Edward M